Table 3 Patient characteristics according to the survival status
30 day survival status | Survivors | Nonsurvivors | p value |
|---|---|---|---|
Number of admissions | 185 (68.8%) | 84 (31.2%) | |
Age | 83 [81–86] | 85 [81–88] | 0.06 |
Male | 85 (45.9%) | 47 (56%) | 0.13 |
APACHE II | 17 [12–23] | 25 [18–32] | < 0.001 |
SAPS II | 37 [29–50] | 48 [39–61] | 0.001 |
SOFA Score | 6 [3–9] | 8 [5–11] | < 0.001 |
Frailty status | |||
Fit (CFS 1–3) | 52 (28.1%) | 12 (14.3%) | 0.014 |
Pre-frail (CFS 4) | 50 (27%) | 11 (13%) | 0.011 |
Frail (CFS 5–9) | 83 (44.9%) | 61 (72.6%) | < 0.001 |
Cause of admission | |||
Acute medical | 85 (45.9%) | 61 (72.6%) | < 0.001 |
Acute surgery | 6 (3.2%) | 6 (7.1%) | 0.15 |
Trauma | 16 (8.6%) | 10 (11.9%) | 0.4 |
Elective surgery | 78 (42.2%) | 7 (8.3%) | < 0.001 |
ICU length of stay (days) | 2.7 [1–8] | 5.2 [2.2–9.8] | 0.012 |
Use of life sustaining treatments | |||
Non-invasive Ventilation | 69 (37.3%) | 28 (33.3%) | 0.53 |
Mechanical ventilation | 74 (40%) | 58 (69%) | < 0.001 |
Vasoactive drugs | 107 (57.8%) | 66 (78.6%) | 0.001 |
Renal replacement therapy | 31 (16.8%) | 27 (32.1%) | 0.004 |
Treatment withheld | 8 (4.3%) | 32 (38.1%) | < 0.001 |
Treatment withdrawn | 1 (0.5%) | 34 (40.5%) | < 0.001 |
ICU mortality | 0 (0%) | 53 (63.1%) | < 0.001 |